Analyst Ratings For IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Today, HC Wainwright initiated coverage on IntelliPharmaCeutics Intl (NASDAQ:IPCI) with a Buy with a price target of $2.50.
Some recent analyst ratings include
- 1/19/2018-HC Wainwright initiated coverage with a Buy rating.
- 9/26/2017-Mackie Upgrade from a “Hold” rating to a “” rating.
- 4/18/2017-Aegis Reiterated Rating of Hold.
Recent Trading Activity for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
Shares of IntelliPharmaCeutics Intl closed the previous trading session at 1.00 up +0.20 24.37% with 0.8801000118255615 shares trading hands.